SCHEMBL24286286

SCHEMBL24286286

COc1cc(S(=O)(=O)N2CCOc3ccc(-c4cccc(C(F)(F)F)n4)cc32)ccc1F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 2/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ ALDH1A1 P00352 1/20 0.44
▸ CYP3A4 P08684 1/20 0.43
▸ CYP2D6 P10635 1/20 0.43
▸ NPC1 O15118 2/20 0.43
▸ MEN1 O00255 2/20 0.42
▸ MAPT P10636 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ TP53 P04637 1/20 0.42
▸ PKM P14618 1/20 0.42
▸ PKLR P30613 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ RORC P51449 8/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ CPT2 P23786 1/20 0.40
▸ CPT1A P50416 1/20 0.40
▸ CPT1B Q92523 1/20 0.40
▸ LMNA P02545 1/20 0.39
▸ SCN9A Q15858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24286236 0.84 PKM (0.52) POLBKMT2APKMPKLRRORC
SCHEMBL24286256 0.82 CYP3A4 (0.53) POLBSMN1; SMN2ALDH1A1CYP3A4CYP2D6
SCHEMBL24286304 0.82 NPC1 (0.52) POLBSMN1; SMN2ALDH1A1CYP3A4CYP2D6
SCHEMBL24286258 0.81 PKM (0.47) NPC1KMT2APKMPKLRRORC
SCHEMBL24286298 0.79 ALDH1A1 (0.49) POLBSMN1; SMN2ALDH1A1CYP3A4CYP2D6
SCHEMBL20957419 0.79 RORC (0.57) RORC
SCHEMBL18312477 0.79 RORC (0.57) RORC
SCHEMBL24286809 0.79 CYP2C9 (0.51) POLBSMN1; SMN2ALDH1A1CYP3A4CYP2D6
SCHEMBL20957275 0.78 RORC (0.47) RORC
SCHEMBL24286787 0.78 RORC (0.46) POLBCYP3A4CYP2D6MEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3307738-B1 ARYL DIHYDRO-2H-BENZO[B][1,4]OXAZINE SULFONAMIDE AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORY AND THE TREATMENT OF DISEASE UNIV MICHIGAN REGENTS (US) 2022-04-20 — — EP disclosed
Send feedback